Cerner Board Members Recognized Among Most Influential Corporate Directors
January 08 2020 - 4:01PM
Cerner Corporation, a global health care technology company,
announced that three board members, Linda Dillman, Julie Gerberding
and Melinda Mount, have been named as WomenInc.’s Most Influential
Corporate Board Directors for their achievements in business and
contributions to advance technology and innovation. The magazine,
which is dedicated to comprehensive coverage of women’s achievement
in business, released the listing in their winter 2019 edition.
“We congratulate Linda, Julie and Melinda for this well-deserved
recognition and their contributions to Cerner,” said Brent Shafer,
chairman & CEO, Cerner. “Health care is constantly impacted by
demographic, technological, political and technical dynamics. The
expertise, leadership and experience that our Board brings helps
Cerner continue evolving in the changing landscape and remain
successful. We are proud and fortunate to have these three
innovative and talented minds working with us.”
WomenInc. recognizes high-achieving women serving on the boards
of S&P 1000 public companies and is the most comprehensive
listing of women executives, influencers and achievers contributing
leadership to corporate boards.
“WomenInc. is proud to recognize this distinguished group of
women serving on public boards,” said Catrina Young, executive vice
president and chief communications officer, WomenInc. “We are
inspired by these accomplished executives, their distinguished
careers and the corporations that demonstrate inclusive board
composition.”
Read more about each recognized Cerner board member below:
Linda
Dillman Linda Dillman is a former chief
information officer for QVC, Inc. Prior to her work at QVC, Dillman
was senior vice president of enterprise services/global functions
IT for Hewlett-Packard Company. She also served as executive vice
president of benefits and risk management and executive vice
president and chief information officer for Wal-Mart Stores, Inc.
Dillman is a member of the GS1 US Board of Governors and the
University of Indianapolis Advisory Board.
Julie
Gerberding Dr. Julie Gerberding is executive
vice president and chief patient officer at Merck & Co., Inc.
Previously, Dr. Gerberding was director of the Centers for Disease
Control, where she led the agency through more than 40 emergency
public health crisis responses. Dr. Gerberding also serves on the
Boards of Biotechnology Innovation Organization (BIO) and the MSD
Wellcome Trust Hilleman Laboratories. Dr. Gerberding has
received more than 50 awards/honors, including recognition by the
U.S. Department of Health and Human Services for her leadership in
responses to anthrax bioterrorism and the Sept. 11 attacks. In
2018, she was selected as the Healthcare Businesswomen
Association’s Woman of the Year and received the Lifetime
Achievement Award from eyeforpharma.
Melinda
Mount Melinda Mount most recently served as the
president of AliphCom, Inc. Previously, she held various senior
level positions at Microsoft Corporation, including corporate vice
president and chief financial officer of the Online Services
Division. Prior to joining Microsoft, Mount served as the vice
president of strategy and development at Time Warner, Inc. and
executive vice president and co-managing director of the United
Kingdom Division of AOL Inc. She also previously served as vice
president of Mergers and Acquisitions at Morgan Stanley. She
is a member of the Board of Directors of the University of
Wisconsin Foundation.
About Cerner Cerner’s health technologies
connect people and information systems at more
than 27,500 contracted provider
facilities worldwide dedicated to creating smarter and
better care for individuals and communities. Recognized globally
for innovation, Cerner assists clinicians in making care
decisions and assists organizations in managing the
health of their populations. The company also offers an
integrated clinical and financial system to help
manage day-to-day revenue functions, as well as a
wide range of services to support clinical, financial and
operational needs, focused on people. For more information,
visit Cerner.com, The Cerner Blog or connect
on Facebook, Instagram, LinkedIn, Twitter or The
Cerner Podcast. Nasdaq: CERN. Smarter Care. Better
Outcomes. Healthier You.
Media Contacts: Shayla Wilkinson,
Public Relations, (816) 718-6988,
Shayla.Wilkinson@cerner.com
Cerner (NASDAQ:CERN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cerner (NASDAQ:CERN)
Historical Stock Chart
From Apr 2023 to Apr 2024